Stoke Therapeutics STOK
NASDAQ STOK
$26.36 +0.36 (+1.38%)
As of: Oct 1, 2026 · 1:50 PM EDT

Stoke Therapeutics (STOK) Other Non-Current Assets (2018 - 2026)

Updated

Stoke Therapeutics (STOK) posted Other Non-Current Assets of $3.23 million for Q2 2026, up 347.6% from $721,000 a year earlier and unchanged from the prior quarter.

Analysis

Stoke Therapeutics (STOK) Other Non-Current Assets (2018 - 2026) Analysis & Trends

At the end of FY2025, Stoke Therapeutics' Other Non-Current Assets came in at $227,000, down 68.5% from FY2024.

  • Annual Other Non-Current Assets shows a five-year compound annual growth rate of 2.1% (FY2020 to FY2025).
  • In prior years, Stoke Therapeutics' Other Non-Current Assets was $721,000 in FY2024 (+26.7%), $569,000 in FY2023 (unchanged), $569,000 in FY2022 (unchanged) and $569,000 in FY2021 (+177.6%).
  • On a year-over-year basis, Other Non-Current Assets increased in six of the last eight quarters, with growth averaging 94.8%.
  • The strongest year-over-year quarter for Other Non-Current Assets in the past five years was Q1 2022, with growth of 881.0%; the weakest was Q4 2025, with a decline of 68.5%.
  • According to Business Quant data, Other Non-Current Assets for the three prior quarters was $3.23 million (Q1 2026), $227,000 (Q4 2025) and $721,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 Stoke Therapeutics 1.62 Bn 453.12 Mn - 3.23 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.23 Mn
Mar 31, 2026 3.23 Mn
Dec 31, 2025 227,000.00
Sep 30, 2025 721,000.00
Jun 30, 2025 721,000.00
Mar 31, 2025 721,000.00
Dec 31, 2024 721,000.00
Sep 30, 2024 494,000.00
Jun 30, 2024 494,000.00
Mar 31, 2024 569,000.00
Dec 31, 2023 569,000.00
Sep 30, 2023 569,000.00
Jun 30, 2023 569,000.00
Mar 31, 2023 569,000.00
Dec 31, 2022 569,000.00
Sep 30, 2022 569,000.00
Jun 30, 2022 569,000.00
Mar 31, 2022 569,000.00
Dec 31, 2021 569,000.00
Sep 30, 2021 569,000.00
API Access

Stoke Therapeutics Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=STOK&period=max&api_key=YOUR_API_KEY